STELARA 45 mg/.5mL
ustekinumab · INJECTION, SOLUTION · Janssen Biotech, Inc.
No Recall History
Plain English
STELARA is a injection, solution containing ustekinumab at 45 mg/.5mL, taken subcutaneous. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- STELARA
- Generic Name
- ustekinumab
- NDC Code (Product)
57894-060- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 45 mg/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125261
- Drug Class
- Interleukin-12 Antagonist [EPC]; Interleukin-23 Antagonist [EPC]
- Marketing Start
- 09/25/2009
Recall History
No Recall HistoryFrequently Asked Questions
What is STELARA used for?
STELARA contains ustekinumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is STELARA a controlled substance?
STELARA is not classified as a controlled substance by the DEA.
What is the generic name for STELARA?
The generic name for STELARA is ustekinumab. There are 10 other brand versions of ustekinumab.
What is the NDC code for STELARA 45 mg/.5mL?
The NDC (National Drug Code) for STELARA 45 mg/.5mL is 57894-060, listed by Janssen Biotech, Inc..